SHUFRO ROSE & CO LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHUFRO ROSE & CO LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$407,440
+0.9%
4,0000.0%0.04%
+2.7%
Q2 2023$403,640
+9.7%
4,0000.0%0.04%
+8.8%
Q1 2023$368,000
+0.4%
4,000
-1.0%
0.03%
+9.7%
Q4 2022$366,509
+18.2%
4,040
-1.0%
0.03%0.0%
Q3 2022$310,000
-9.4%
4,080
+1.0%
0.03%
+3.3%
Q2 2022$342,000
-8.1%
4,040
-4.7%
0.03%
+3.4%
Q1 2022$372,000
+0.3%
4,2400.0%0.03%
+7.4%
Q4 2021$371,000
+6.9%
4,2400.0%0.03%0.0%
Q3 2021$347,000
-18.0%
4,240
-8.6%
0.03%
-15.6%
Q2 2021$423,000
+6.5%
4,6400.0%0.03%
+3.2%
Q1 2021$397,000
-18.6%
4,640
-10.2%
0.03%
-24.4%
Q4 2020$488,000
+8.9%
5,168
+0.3%
0.04%
-4.7%
Q3 2020$448,000
+3.5%
5,155
+4.0%
0.04%0.0%
Q2 2020$433,000
+5.9%
4,9550.0%0.04%
-12.2%
Q1 2020$409,000
-12.8%
4,9550.0%0.05%
+16.7%
Q4 2019$469,000
+8.8%
4,9550.0%0.04%
-2.3%
Q3 2019$431,000
-4.6%
4,9550.0%0.04%
-2.3%
Q2 2019$452,000
-72.3%
4,955
-70.8%
0.04%
-73.0%
Q1 2019$1,631,000
+12.0%
16,9620.0%0.16%
+1.2%
Q4 2018$1,456,000
-0.3%
16,9620.0%0.16%
+18.4%
Q3 2018$1,461,000
+16.2%
16,962
+2.0%
0.14%
+13.3%
Q2 2018$1,257,000
-7.6%
16,637
-1.1%
0.12%
-10.4%
Q1 2018$1,360,000
-5.9%
16,822
-2.3%
0.13%
-5.6%
Q4 2017$1,446,000
-2.2%
17,2220.0%0.14%
-4.7%
Q3 2017$1,479,000
+8.1%
17,222
+5.1%
0.15%
+2.1%
Q2 2017$1,368,000
+13.8%
16,382
+1.2%
0.15%
+12.3%
Q1 2017$1,202,000
+2.0%
16,1820.0%0.13%
-1.5%
Q4 2016$1,179,000
-7.7%
16,1820.0%0.13%
-7.7%
Q3 2016$1,278,000
-13.7%
16,182
-9.9%
0.14%
-12.8%
Q2 2016$1,481,000
+13.9%
17,9520.0%0.16%
+13.1%
Q1 2016$1,300,000
-7.7%
17,952
+9.6%
0.14%
-10.5%
Q4 2015$1,409,000
-8.5%
16,382
-2.2%
0.16%
-12.4%
Q3 2015$1,540,000
-6.5%
16,7570.0%0.18%
+5.7%
Q2 2015$1,647,000
-0.3%
16,7570.0%0.18%
+2.9%
Q1 2015$1,652,000
+6.6%
16,757
+0.2%
0.17%
+7.6%
Q4 2014$1,549,000
-1.6%
16,7250.0%0.16%
-3.1%
Q3 2014$1,574,000
+4.0%
16,7250.0%0.16%
+5.2%
Q2 2014$1,514,000
+6.5%
16,7250.0%0.16%
+4.0%
Q1 2014$1,421,000
+5.7%
16,7250.0%0.15%
+4.9%
Q4 2013$1,344,000
+4.8%
16,7250.0%0.14%
-2.7%
Q3 2013$1,282,000
+84.7%
16,725
+70.4%
0.15%
+78.0%
Q2 2013$694,000
+151.4%
9,815
+117.4%
0.08%
+127.8%
Q3 2012$276,0004,5150.04%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders